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Abstract
Objective:  Childhood  obesity  has  been  associated  with  metabolic  syndrome  and  cardiovascu-
lar diseases.  This  study  aimed  to  compare  plasma  levels  of  traditional  metabolic  markers,
adipokines  and  soluble  tumor  necrosis  factor  receptor  type  1  (sTNFR1)  in  overweight,  obese  and
lean children.  We  also  assessed  the  relationships  of  these  molecules  with  classical  metabolic
risk factors.
Methods:  This  study  included  104  children  and  adolescents,  which  were  grouped  as:  lean
(n =  24),  overweight  (n  =  30),  and  obese  subjects  (n  =  50).  They  were  subjected  to  anthropo-
metrical,  clinical  and  laboratorial  measurements.  All  measurements  were  compared  between
groups. Correlation  analyses  were  also  performed  to  evaluate  the  association  between  clinical
data, traditional  metabolic  markers,  adipokines  and  sTNFR1.
Results:  Fasting  glucose,  insulin,  homeostatic  model  assessment  of  insulin  resistance  (HOMA-
IR), LDL-cholesterol  and  triglycerides  were  comparable  in  lean,  overweight  and  obese  subjects.
Plasma levels  of  sTNFR1  were  similar  in  lean  and  overweight  subjects,  but  signiﬁcantly  increased
in obese  group.  Leptin,  adiponectin  and  resistin  levels  did  not  differ  when  overweight  were  com-
pared to  obese  subjects.  However,  all  adipokines  differed  signiﬁcantly  when  lean  subjects  were
compared  to  overweight  and  obese  individuals.  Plasma  levels  of  adiponectin  were  negatively
correlated with  body  mass  index  (BMI),  whereas  leptin,  resistin  and  sTNFR1  concentrations
positively correlated  with  BMI.
 Please cite this article as: Mantovani RM, Rocha NP, Magalhães DM, Barbosa IG, Teixeira AL, Simões e Silva AC. Early changes in adipokines
rom overweight to obesity in children and adolescents. J Pediatr (Rio J). 2016;92:624--30.
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Conclusion:  Our  results  showed  signiﬁcant  differences  in  circulating  levels  of  the  evaluated
markers  when  lean,  overweight  and  obese  individuals  were  compared,  suggesting  that  these
biomarkers  may  change  from  lean  to  overweight  and  from  overweight  to  obesity.
© 2016  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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em  crianc¸as e  adolescentes
Resumo
Objetivo:  A  obesidade  na  infância  tem  sido  associada  à  síndrome  metabólica  e  a  doenc¸as  cardio-
vasculares. O  objetivo  deste  estudo  foi  comparar  níveis  plasmáticos  de  marcadores  metabólicos
tradicionais,  adipocinas  e  do  receptor  solúvel  de  fator  de  necrose  tumoral  tipo  1  (sTNFR1)  em
crianc¸as com  sobrepeso,  obesas  e  magras.  Também  avaliamos  as  relac¸ões  dessas  moléculas  com
fatores de  risco  metabólico  clássicos.
Métodos:  Este  estudo  incluiu  104  crianc¸as  e  adolescentes,  agrupados  da  seguinte  forma:  indiví-
duos magros  (n  =  24),  com  sobrepeso  (n  =  30)  e  obesos  (n  =  50).  Eles  foram  submetidos  a  medic¸ões
antropométricas,  clínicas  e  laboratoriais.  Todas  as  medic¸ões  foram  comparadas  entre  os  grupos.
Também  foram  realizadas  análises  de  correlac¸ão  para  avaliar  a  associac¸ão  entre  dados  clínicos,
marcadores  metabólicos  tradicionais,  adipocinas  e  sTNFR1.
Resultados:  Glicemia  de  jejum,  insulina,  modelo  de  avaliac¸ão  da  homeostase  da  resistência  à
insulina (HOMA-IR),  colesterol  LDL  e  triglicerídeos  foram  comparáveis  em  indivíduos  magros,
com sobrepeso  e  obesos.  Os  níveis  plasmáticos  de  sTNFR1  foram  similares  em  indivíduos  magros
e com  sobrepeso,  porém  signiﬁcativamente  maiores  no  grupo  obeso.  Os  níveis  de  leptina,
adiponectina  e  resistina  não  diferiram  quando  indivíduos  com  sobrepeso  foram  comparados  aos
obesos. Contudo,  todas  as  adipocinas  diferiram  signiﬁcativamente  quando  indivíduos  magros
foram comparados  a  indivíduos  com  sobrepeso  e  obesos.  Os  níveis  plasmáticos  de  adiponectina
estavam negativamente  correlacionados  ao  índice  de  massa  corporal  (IMC),  ao  passo  que  as
concentrac¸ões de  leptina,  resistina  e  sTNFR1  estavam  positivamente  correlacionadas  ao  IMC.
Conclusão:  Nossos  resultados  mostraram  diferenc¸as  signiﬁcativas  nos  níveis  circulantes  dos
marcadores  avaliados  ao  comparar  indivíduos  magros,  com  sobrepeso  e  obesos,  sugerindo  que
esses biomarcadores  poderão  mudar  de  indivíduos  magros  para  indivíduos  com  sobrepeso  e  de
indivíduos  com  sobrepeso  para  obesos.
© 2016  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um  artigo
Open Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.
0/).
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Childhood  obesity  is  increasing  in  prevalence  and  is  strongly
associated  with  obesity  in  adulthood.1,2 Obese  children  are
at  risk  of  metabolic  syndrome,  cardiovascular  diseases,  and
increased  adult  morbidity  and  mortality.3,4
Adipokines  are  hormones  secreted  by  adipose  tissue
that  play  a  role  in  metabolic  homeostasis.5 Obesity  also
induces  production  of  inﬂammatory  cytokines  and  inﬁltra-
tion  of  immune  cells  into  adipose  tissue,  determining  a
state  of  chronic  low-grade  inﬂammation.  Metabolic  inﬂam-
mation  has  been  recognized  as  a  unifying  mechanism
linking  obesity  to  a  broad  spectrum  of  conditions,  such
as  atherosclerosis,  type  2  diabetes,  and  systemic  vascular
complications.5--7
The  current  study  analyzed  plasma  levels  of  adipokines
(adiponectin,  resistin,  and  leptin),  and  soluble  tumor  necro-
sis  factor  receptor  type  1  (sTNFR1),  insulin  sensitivity,  and
lipid  metabolism  in  overweight  and  obese  children  and  ado-
lescents  in  comparison  with  lean  individuals.  The  authors
t
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olso  assessed  the  relationships  of  these  molecules  with  clas-
ical  metabolic  risk  factors.  Circulating  levels  of  sTNFR1
re  regarded  as  inﬂammatory  markers,  reﬂecting  TNF-
ctivity  better  than  the  measurement  of  TNF- itself.5--9 It
as  hypothesized  that  adipokines,  low-grade  inﬂammation,
nsulin  sensitivity,  and  lipid  metabolism  gradually  change
rom  lean  to  overweight  and  from  overweight  to  obesity.
ethods
ubjects
his  cross  sectional  study  had  a  convenience  sample  of  104
hildren  and  adolescents,  aged  6--18  years  old.  All  indi-
iduals  who  fulﬁlled  the  inclusion  criteria  and  accepted
aking  part  in  the  study  were  recruited  from  the  Pediatric
ndocrinology  Service  and  the  Pediatric  Primary  Care  Cen-
er  of  the  institution  for  two  years.  Therefore,  50  obese,  30
verweight,  and  24  lean  individuals  were  evaluated.
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nclusion  criteria
he  criterion  for  obesity  was  body  mass  index  (BMI)  greater
han  the  95th  percentile  for  age  and  sex  according  to  the
ational  Center  for  Health  Statistics  (NCHS)  standards.10
verweight  was  deﬁned  as  BMI  percentiles  for  age  and  sex
f  >85th  and  <95th.  The  lean  group  included  subjects  with
MI  percentiles  >10th  and  <85th  for  age  and  sex.
xclusion  criteria
ubjects  with  genetic  disorders,  secondary  obesity,  and
omorbidities  such  as  diabetes,  cardiac,  pulmonary  and
eurological  diseases,  or  acute  infections  were  excluded.
ubjects  receiving  medical  therapy  were  also  ineligible.
ealth  status  was  determined  through  medical  history  and
ither  parental  report  or  self-report  to  rule  out  chronic  or
cute  diseases.
tudy  protocol
t  admission,  all  subjects  underwent  clinical  examination
ncluding  weight,  height,  BMI,  blood  pressure,  abdominal
ircumference  (AC),  and  pubertal  stage  evaluation.  Weight
as  obtained  to  the  nearest  0.1  kg  using  calibrated  digital
cales.  Standing  height  was  considered  as  the  average  of
hree  measures,  in  the  nearest  millimeter,  using  a  ﬁxed  sta-
iometer.  AC  was  obtained  with  tape  measure  at  just  above
he  uppermost  lateral  border  of  the  right  ileum,  at  the  end
f  a  normal  expiration,  and  was  recorded  to  the  nearest  mil-
imeter,  as  recommended  by  the  NCHS.11 Pubertal  stage  was
etermined  according  to  Tanner  criteria,12 and  the  patients
ere  classiﬁed:  (i)  pre-pubertal:  boys  at  genital  stage  I,  girls
t  breast  stage  I;  (ii)  early-puberty  boys  at  genital  stage
I--III,  girls  at  breast  stage  II--III;  (iii)  late/post  pubertal:  boys
t  genital  stage  ≥IV,  girls  at  breast  stage  ≥IV.  Systolic  and
iastolic  blood  pressures  were  measured  on  three  different
ccasions,  in  the  right  arm,  after  a  10-min  rest  in  the  supine
osition  using  a  calibrated  sphygmomanometer,  and  the  two
alues  were  averaged.  Blood  pressure  measurements  were
lso  evaluated  following  the  recommendations  of  the  Fourth
ask  Force  Report.13
lood  sampling
fter  informed  consent,  all  subjects  were  submitted  to
lood  collection  for  the  measurement  of  fasting  glucose,
nsulin,  total  cholesterol,  high-density  lipoprotein  (HDL)
holesterol,  low-density  lipoprotein  (LDL)  cholesterol,  very
ow-density  lipoprotein  (VLDL)  cholesterol,  triglycerides,
diponectin,  leptin,  resistin,  and  sTNFR1.  Blood  samp-
ing  occurred  at  one  occasion  after  an  overnight  fast
f  12  h  through  peripheral  venous  puncture.  One  sample
as  taken  for  fasting  glucose,  insulin,  total  cholesterol,
DL-cholesterol,  LDL-cholesterol,  and  triglycerides  mea-
urements,  according  to  standard  recommendations.  The
econd  sample  was  for  adiponectin,  leptin,  resistin,  and
TNFR1  measurements.  For  these  measurements,  samples
ere  immediately  immersed  in  ice,  and  processed  within
0  min  after  collection.  Cells  were  centrifuged  at  700  ×  g
or  10  min  at  4 ◦C;  then  supernatant  plasma  was  collected
nd  re-spun  for  another  20  min  at  1300  ×  g  to  sediment  the
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latelets.  Cell-free  plasma  was  aliquoted  into  0.5  mL  sam-
les  and  stored  at  −80 ◦C  until  measurements.
easurements
asting  glucose,  cholesterol,  and  triglycerides  levels
ere  determined  by  enzymatic  colorimetric  assay  (Advia
hemistry®;  Siemens®; LA,  USA),  while  insulin  was  mea-
ured  by  chemiluminescence  (reference  value:  <29  IU/mL;
Immulite® 2000,  LA,  USA).  The  insulin  resistance  was  esti-
ated  by  the  homeostasis  model  assessment  for  insulin
esistance  (HOMA-IR).14 Plasma  levels  of  adiponectin,  leptin,
esistin,  and  sTNFR1  were  measured  by  speciﬁc  ELISA  kits
R&D  Systems®,  Minneapolis,  USA),  following  the  manufac-
urer’s  instructions.  All  samples  were  assayed  in  duplicate
uring  a  single  assay  to  avoid  inter-assay  variation.  The
ntra-assay  variation  was  below  3%.  The  detection  limits
ere  5  pg/mL  for  adiponectin,  resistin,  and  leptin;  10  pg/mL
or  sTNFR1.
tatistical  analysis
tatistical  analyses  were  performed  using  SPSS  software
ersion  19.0  (SPSS  Inc,  Chicago,  USA).  Sample  size  was
stimated  as  at  least  a total  of  96  individuals,  consider-
ng  a  power  of  0.80  (1  −  ˇ),  a  difference  of  20%  between
roups,  a  signiﬁcance  (˛)  level  of  0.05,  and  a standard
eviation  no  greater  than  25%.  All  variables  were  tested
or  normality  of  distribution  by  the  Shapiro--Wilk  test.
ssociation  between  dichotomous  variables  was  assessed
y  chi-squared  or  Fisher’s  exact  test.  Differences  among
roups  were  compared  using  the  Kruskal--Wallis  test  with
unn’s  multiple  comparison  post-test.  Spearmann’s  correla-
ion  analyses  were  performed  to  examine  the  relationship
etween  adipokines,  sTNFR1  levels,  and  age,  BMI,  glucose,
nsulin,  HOMA-IR,  HDL-cholesterol,  LDL-cholesterol,  and  tri-
lycerides.  The  signiﬁcance  level  was  set  at  p  <  0.05.
thical  issues
he  Ethics  Committee  of  the  institution  approved  the  study
ccording  to  the  protocol  ETIC  0415/06.  Informed  consent
as  obtained  from  subjects  and  their  parents.  The  research
rotocol  did  not  interfere  with  any  medical  prescriptions
nd  follow-up  was  guaranteed  even  in  cases  of  refusal  to
articipate  in  the  study.
esults
nthropometrical,  clinical,  and  laboratorial
haracteristics  in  obese,  overweight,  and  lean
roups
ubjects  were  allocated  into  three  groups:  lean  (n  =  24,
4.2%  female),  overweight  (n  =  30,  80%  female),  and  obese
ubjects  (n  =  50,  44%  female).  Anthropometrical,  clinical,
nd  laboratorial  characteristics  are  displayed  in  Table  1.
ean  and  obese  subjects  were  comparable  regarding  age  and
ender  distribution.  There  was  an  increased  frequency  of
emales  in  the  overweight  group  in  comparison  with  obese
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Table  1  Clinical  and  laboratory  characteristics  (mean  ±  SD)  for  lean,  overweight,  and  obese  subjects.
Characteristic  Lean  (n  =  24)  A  Overweight  (n  =  30)  B  Obese  (n  =  50)  C  p-value
Age  in  years  10.93  (±2.57)  12.28  (±2.61)  10.65  (±2.59)  0.23a
Female  gender  (%)  54.2  80.0  44.0  0.007b
Tanner’s  stage  (%)  <0.001b
Pre-pubertal  25.0  0  6.0
Early-puberty  41.7  40.0  72.0
Late/postpubertal  33.3  60.0  22.0
BMI 17.39  (±3.65)  23.76  (±2.64)  28.60  (±7.68)  0.001a
A  <  B  <  Cc
AC/height  ratio 0.46  (±0.05) 0.56  (±0.03) 0.63  (±0.08) <0.001a
A  <  B  <  Cc
Blood  pressure  classiﬁcation  (%)  0.003b
Normotensive  100  66.7  48.9
Pre-hypertensive 0  10.0  19.1
Hypertensive  0  6.7  31.9
Glucose (mmol/L)  85.15  (±8.74)  82.82  (±6.12)  82.08  (±7.73)  0.22a
Insulin  (U/mL)  13.31  (±30.78)  11.85  (±12.99)  15.77  (±27.25)  0.14a
HOMA-IR  3.18  (±7.69)  2.49  (±2.71)  3.50  (±6.45)  0.16a
HDL-cholesterol  (mg/mL)  55.15  (±12.88)  47.38  (±9.53)  45.83  (±10.63)  0.03a
A  =  Bc;  B  =  Cc;
A  >  Cc
LDL-cholesterol  (mg/mL)  87.25  (±13.78)  99.32  (±23.24)  94.22  (±30.41)  0.39a
Triglycerides  (mg/mL)  60.83  (±34.83)  71.92  (±31.57)  82.50  (±41.37)  0.16a
sTNFR1  plasma  levels  (pg/mL)  (±SD)  623.75  (±347.14)  624.73  (±191.30)  855.14  (±269.42)  <0.001a
A  =  Bc;  A  <  Cc;
B <  Cc
BMI, body mass index; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment for insulin resistance; LDL, low-density
lipoprotein; SD, standard deviation; sTNFR, soluble tumor necrosis factor.
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obese  vs.  lean,  Fig.  1]).
In  order  to  evaluate  gender  inﬂuence,  this  study  also
compared  plasma  levels  of  adipokines  in  males  vs.  females
for  each  group  (lean,  overweight,  and  obese  subjects),
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subjects  (p  =  0.02).  In  the  univariate  analysis,  the  groups
differed  according  to  Tanner  stage,  BMI,  AC/height,  blood
pressure  classiﬁcation,  and  HDL  cholesterol  levels  (p  <  0.05,
Table  1).  The  obese  group  had  signiﬁcantly  higher  BMI,
AC/height  ratio,  and  prevalence  of  hypertension  than  lean
and  overweight  subjects.  HDL  cholesterol  levels  were  signiﬁ-
cantly  lower  in  both  the  obese  and  overweight  groups  than  in
lean  individuals.  However,  fasting  glucose,  insulin,  HOMA-IR,
LDL  cholesterol,  and  triglycerides  were  comparable  in  lean,
overweight,  and  obese  subjects  (p  >  0.05,  Table  1).
As  also  shown  in  Table  1,  plasma  levels  of  sTNFR1  were
similar  in  lean  and  overweight  subjects  (p  >  0.05),  but  were
signiﬁcantly  increased  in  obese  subjects  (p  <  0.01  overweight
vs.  obese  and  p  <  0.001  lean  vs.  obese).
Fig.  1  shows  plasma  levels  of  adiponectin,  resistin,  and
leptin  in  obese,  overweight,  and  lean  subjects.  Adipokines
did  not  differ  when  overweight  were  compared  to  obese  sub-
jects  (Fig.  1).  Adiponectin  levels  (pg/mL)  were  decreased  in
overweight  and  obese  subjects  in  comparison  with  lean  sub-
jects  (5199.18  in  lean  subjects;  4537.57  in  the  overweight
group;  3467.57  in  the  obese  group  [p  <  0.001  overweight  vs.
lean  and  p  <  0.001  obese  vs.  lean,  Fig.  1]).  Plasma  levels
of  resistin  (pg/mL)  were  increased  in  the  overweight  and
obese  groups  in  comparison  with  lean  subjects  (1140.38  in
the  lean  group;  1788.51  in  the  overweight  group;  2256.39
F
(
j
*n  the  obese  group  [p  <  0.001  overweight  vs.  lean  and
 <  0.001  obese  vs.  lean,  Fig.  1]).  The  same  proﬁle  was
etected  for  leptin  levels  (702.54  pg/mL  in  the  lean  group;
933.04  pg/mL  in  the  overweight  group;  1965.91  pg/mL  in
he  obese  group  [p  <  0.001  overweight  vs.  lean  and  p  <  0.001igure  1  Plasma  levels  of  adiponectin,  resistin,  and  leptin
pg/mL)  in  lean  (n  =  24),  overweight  (n  =  30),  and  obese  sub-
ects (n  =  50).  *  p  <  0.01  (Kruskal--Walis,  Dunn’s  post  hoc  test).
* p  <  0.001  (Kruskal--Walis,  Dunn’s  post  hoc  test).
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Figure  2  Gender  inﬂuence  on  plasma  levels  of  adipokines
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18pg/mL)  in  lean  (n  =  24),  overweight  (n  =  30),  and  obese  sub-
ects (n  =  50).  A,  adiponectin;  B,  leptin;  C,  resistin.  *  p  <  0.01.
* p  <  0.001  Mann--Whitney  test.
s  shown  in  Fig.  2.  In  the  lean  group,  males  presented
igher  levels  of  adiponectin  (5642.81  vs.  4983.64  pg/mL
n  females,  p  =  0.005)  and  lower  concentrations  of  leptin
han  females  (371.79  pg/mL  in  males  vs.  1391.26  pg/mL  in
emales,  p  < 0.001).  No  other  marker  differed  when  com-
aring  males  and  females.  No  differences  were  detected  in
eptin,  resistin,  and  adiponectin  levels  for  the  comparisons
etween  male  and  females  in  overweight  and  obese  groups
Fig.  2).
To  investigate  a  potential  interference  of  Tanner’s  stage,
he  levels  of  adipokines  in  pre-pubertal  vs.  early  puberty
s.  late  puberty  were  compared  for  each  group  (lean,
verweight,  and  obese  individuals).  No  differences  were
etected  in  resistin  and  adiponectin  levels  for  the  compar-
sons  between  Tanner’s  stages  classiﬁcation  in  all  groups.
eptin  levels  exhibited  a  mild  increase  according  to  the  pro-
ression  of  Tanner’s  stage  only  in  the  obese  group  (data  not
hown).orrelation  analysis
onsidering  all  subjects  (n  =  104),  plasma  levels  of
diponectin  were  negatively  correlated  with  BMI
d
v
i
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p  <  0.001;    =  −0.402),  insulin  (p  =  0.02;    =  −0.247),
OMA-IR  (p  =  0.02;    =  −0.263),  and  triglycerides  (p  =  0.02;
 =  −0.261).  Leptin  levels  were  positively  correlated  with
ge  (p  <  0.001;    = 0.425),  BMI  (p  <  0.001;    =  0.577),  insulin
p  <  0.001;    =  0.500),  HOMA-IR  (p  <  0.001;    =  0.497),  tri-
lycerides  (p  =  0.003;    =  0.325),  and  negatively  correlated
ith  HDL-cholesterol  (p  =  0.03;    =  −0.240).  Resistin  con-
entrations  were  positively  correlated  with  BMI  (p  <  0.001;
 =  0.469),  and  negatively  correlated  with  HDL-cholesterol
p  =  0.02;    =  −0.247).  Plasma  levels  of  sTNFR1  were
ositively  correlated  with  BMI  (p  <  0.001;    =  0.338)  and
egatively  correlated  with  adiponectin  levels  (p  =  0.03;
 = −0.212).
iscussion
his  study  showed  that  circulating  levels  of  adipokines
iscriminated  lean  from  overweight/obese  subjects.  Over-
eight  and  obese  individuals  presented  similar  levels  of
ll  the  evaluated  adipokines.  Remarkably,  adiponectin  lev-
ls  were  decreased  while  leptin  and  resistin  levels  were
ncreased  in  overweight  and  obese  groups  in  comparison
ith  lean  controls.  Traditional  metabolic  parameters  were
imilar  in  all  groups,  while  sTNFR1  levels  were  increased
n  the  obese  in  comparison  with  the  overweight  and  lean
roups.
Fasting  plasma  glucose,  insulin,  HOMA-IR,  LDL  choles-
erol,  and  triglycerides  are  traditionally  used  to  assess
etabolic  and  cardiovascular  risks  in  obesity,15 and  their
ean  values  were  comparable  among  lean,  overweight,
nd  obese  groups  in  the  present  study.  On  the  other
and,  sTNFR1  levels  were  higher  in  obese  individuals  than
n  the  lean  or  overweight  groups.  Increased  levels  of
TNFR1  support  the  general  idea  of  a  low-grade  inﬂam-
atory  state  in  obesity.5,8,9 Furthermore,  adipokines  were
igniﬁcantly  altered  in  subjects  with  overweight  and  obe-
ity  in  comparison  with  lean  individuals,  suggesting  that
dipokines  might  be  early  markers  of  changing  from  lean
o  overweight/obesity  status,  even  before  the  occurrence
f  metabolic  alterations.  Similarly,  other  studies  have
hown  that  serum  levels  of  leptin  and  resistin  were  signif-
cantly  higher  in  obese  children  than  in  lean  children.16--18
n  addition,  BMI  positively  correlated  with  leptin  and
esistin,  and  negatively  with  adiponectin  levels,  as  previ-
usly  described.17--20 In  contrast,  another  study  reported
imilar  levels  of  resistin  in  obese  and  lean  subjects.21 Nev-
rtheless,  when  obese  children  were  stratiﬁed  by  insulin
esistance  values,  obese  children  with  insulin  resistance  had
igher  resistin  levels  than  children  with  normal  weight  or
bese  children  without  insulin  resistance.21 Corroborating
he  present  data,  Adamska  et  al.  reported  increased  levels
f  sTNFR1  and  reduced  levels  of  adiponectin  in  overweight
nd  obese  adults  compared  with  lean  subjects.9 On  the  other
and,  the  relation  between  sTNFR  and  BMI  is  controversial.
hereas  there  was  also  positive  correlation  between  BMI
nd  sTNFR1  in  the  present  sample,  Huang  et  al.  did  not
etect  any  association. No  signiﬁcant  correlation  was  pre-
iously  observed  among  sTNFRs  and  lipid  proﬁle,18,22 while,
n  the  present  study,  sTNFR1  was  negatively  correlated  with
DL-cholesterol.
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There  is  a  paucity  of  data  on  the  role  of  adipokines
in  the  transition  from  lean  to  overweight  and  from  over-
weight  to  obesity,  especially  in  pediatric  patients  without
metabolic  syndrome  or  comorbidities.  In  comparison  with
the  control  group,  it  was  found  that  circulating  levels  of
adipokines  are  already  changed  in  overweight  subjects,
who  present  a  similar  proﬁle  to  the  obese  group.  Similarly,
Ko  et  al.  have  shown  that  leptin  levels  were  associated
with  increased  risk  of  children  being  overweight.17 Leptin
is  critical  for  metabolic  regulation  by  signaling  nutritional
status  to  the  hypothalamus,  which,  in  turn,  produces  neuro-
peptides  and  neurotransmitters  to  modulate  food  intake  and
energy  expenditure.5,23 Leptin  levels  positively  correlated
with  insulin,  HOMA-IR,  and  triglycerides;  they  negatively
correlated  with  HDL  cholesterol.17 Johnson  et  al.  found  a  sig-
niﬁcant  association  between  leptin  levels  and  increasing  fat
mass  in  children.24 Two  possible  explanations  are  that  resis-
tance  to  leptin  actions  at  the  receptor  level  might  contribute
to  overweight  and  that  homeostatic  alterations  precede  the
occurrence  of  obesity.25,26
In  the  present  study,  plasma  levels  of  adiponectin
negatively  correlated  with  insulin,  HOMA-IR,  and  triglyceri-
des,  while  leptin  concentrations  were  positively  correlated
with  the  same  metabolic  parameters.  Adamska  and  co-
workers  showed  that  insulin  sensitivity  positively  correlated
to  adiponectin  and  negatively  correlated  to  sTNFR1  and
sTNFR2  levels  in  obese  adults.  Soluble  TNF  receptors
and  adiponectin  also  negatively  correlated  with  insulin
sensitivity,  and  these  markers  have  multiple  effects  on  glu-
cose  and  lipid  metabolism  in  obesity.9 Plasma  levels  of
adiponectin  negatively  correlated  with  insulin,  HOMA-IR,
and  triglycerides21,27 and  positively  correlated  with  insulin
sensitivity.9 The  present  results  also  showed  a  negative
correlation  between  sTNFR1  and  adiponectin  levels,  sup-
porting  the  general  idea  that  increased  concentrations
of  adiponectin  may  compensate  low-grade  inﬂammation.
Indeed,  adiponectin  has  anti-inﬂammatory  effects  that  con-
tribute  to  its  protective  role  against  metabolic  stress  in
obesity.5,28 In  this  context,  increased  concentrations  of
adiponectin  may  be  related  to  better  metabolic  proﬁle
despite  the  greater  fat  mass.  However,  the  majority  of
studies  included  obese  adults  already  exhibiting  signiﬁcant
changes  in  metabolic  parameters,  while  the  present  sam-
ple  only  had  pediatric  individuals  without  co-morbidities  or
metabolic  syndrome.  Therefore,  reduction  of  adiponectin
levels  seems  to  occur  later  than  changes  in  leptin  con-
centrations,  but  may  come  before  metabolic  alterations  in
pediatric  obesity.
Circulating  levels  of  resistin  have  also  been  positively
associated  with  body  fat  mass.29,30 Accordingly,  a  study  with
Mexican  children  and  adolescents  found  negative  correla-
tion  between  resistin  and  HDL-cholesterol  levels.18 Studies
have  also  associated  high  resistin  levels  with  increased
risk  for  metabolic  and  cardiovascular  diseases.5 Similarly  to
adiponectin,  the  elevation  of  resistin  levels  probably  pre-
cedes  co-morbidities  related  to  obesity  in  pediatric  patients.
The  authors  are  aware  of  the  limitations  of  this  study.
First,  the  cross  sectional  design  precludes  the  evaluation
of  interactions  among  variables.  Second,  the  sample  was
relatively  small,  mostly  considering  overweight  and  lean
subjects.  Third,  the  use  of  a  convenience  sample  makes
homogeneity  among  the  selected  groups  very  difﬁcult  to629
btain,  since  differences  in  gender  and  Tanner’s  stage  may
hange  adipokine  levels.  However,  no  differences  were
etected  in  resistin  and  adiponectin  levels  for  the  compar-
sons  between  male  and  females  and  between  Tanner’s  stage
n  the  overweight  and  obese  groups.  Leptin  levels  only  exhib-
ted  a  mild  elevation  according  to  Tanner’s  stage  in  obese
roup.  Nevertheless,  other  aspects  increase  the  strength  of
he  ﬁndings,  such  as  strict  inclusion  and  exclusion  criteria,
ell-established  protocol  for  measurements,  and  a  repre-
entative  number  of  obese  individuals.
In  conclusion,  the  ﬁndings  suggest  that  changes  in  plasma
evels  of  adipokines  (leptin,  resistin,  and  adiponectin)  may
ome  before  alterations  in  traditional  metabolic  markers
f  obesity  in  pediatric  patients.  Longitudinal  studies  with
arger  samples  are  necessary  to  elucidate  how  adipokines
nteract  with  clinical,  metabolic,  and  inﬂammatory  markers
n  pediatric  obesity.
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